-
By including ordinary people, researchers could create consent forms, and a consenting process, that is primarily suited to meeting the needs of potential participants.
-
Keep in mind the person who has who to digest informed consent information. Avoiding complex terminology could lead to better understanding among the laypeople who participate in clinical trials.
-
Some ethicists are unaware of how code status options are named and defined at their institutions. Researchers found that at some hospitals, code status options in the electronic medical record did not even match what was in the hospital policy. Ethics should be one of the experts in this area.
-
Researchers hope leaders can use these data to decide what resources to devote to ethics consultation.
-
Numerous real-life examples of artificial intelligence in healthcare already pose difficult ethical questions: Informed consent, patient privacy, transparency, allocation, and safety are a few. The authors of a recent paper argued artificial intelligence-related ethics training should begin in medical school.
-
Despite ongoing efforts to address disparities in Alzheimer’s disease and dementia care, much work remains. The authors of a recent report identified some of the barriers diverse populations are facing in accessing and receiving dementia care.
-
The first new Alzheimer’s drug to be approved in almost 20 years has sparked a major ethical controversy, leading to protest resignations, criticism, qualifying statements, and even calls for investigations.
-
But randomized trials are needed to better detail long-term risk-benefit ratio.
-
Around 2,000 Americans younger than age 25 die each year because of sudden cardiac death.
-
A systematic review of recent studies of the effects of chamomile on metabolic profiles suggests a positive effect on glycemic control, lipid profiles, and diabetic complications.